HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Clinical evidence / January 17, 2026

Clinical evidence enters the government-to-government record.

CHP reports CMS acknowledgment of its Rampart™ DL Matrix real-world evidence submission.

Timeline: evidence submitted November 2025, receipt confirmed January 17, 2026

Clear Health Pass received government-to-government receipt confirmation for the Consortium’s Rampart™ DL Matrix post-market clinical evidence, submitted under LCD L35041.

The submission was led by Principal Investigator David Burke, MD, MA and delivered in November 2025. CMS acknowledged the submission and forwarded it to the Medicare Administrative Contractors.

Receipt is a milestone in the process

An acknowledgment of receipt is not approval of the study, an endorsement of a product, or a coverage determination. The submission forms part of the company-reported federal engagement history.